Equine neorickettsiosis: A global perspective of the natural habitat of the bacteria and clinical disease.

Equine neorickettsiosis is a bacterial disease affecting horses worldwide, caused by bacteria living inside parasitic worms, leading to symptoms like fever, diarrhea, and colic. This study provides a comprehensive overview of the bacteria’s natural habitat, disease occurrence, clinical signs, diagnosis, treatment, and challenges in prevention.

Overview of Equine Neorickettsiosis

• Equine neorickettsiosis (EN) is a systemic infectious disease affecting horses.
• Caused by intracellular bacteria Neorickettsia risticii and N. findlayensis.
• It is non-contagious, meaning it does not spread directly horse-to-horse.

Geographical Distribution

• EN is endemic in multiple regions of the United States and Canada.
• Also reported in South American countries such as Uruguay and Brazil.
• Indicates a global presence in various climatic and ecological zones.

Natural Habitat and Transmission Cycle of the Bacteria

• Neorickettsia bacteria reside as endosymbionts inside digenean trematodes, which are parasitic flatworms.
• Trematodes undergo a complex life cycle involving multiple hosts:
  • First intermediate host: molluscs (such as snails).
  • Second intermediate host: diverse invertebrates or vertebrates, often aquatic insects.
  • Definitive host: vertebrates where sexual reproduction of the trematode occurs.
• Horses are accidental (“aberrant”) hosts, infected by ingesting aquatic insects infected with Neorickettsia-containing trematodes.

Clinical Presentation in Horses

• Non-specific early signs include:
  • Fever
  • Lethargy (lack of energy)
  • Anorexia (loss of appetite)
• Common gastrointestinal symptoms:
  • Alterations in intestinal motility
  • Colic (abdominal pain)
  • Watery diarrhea
• Other serious complications observed:
  • Acute laminitis (inflammation of the tissues in the hoof)
  • Abortions in pregnant mares

Diagnosis

• Molecular detection methods (such as PCR) targeting bacterial nucleic acids are preferred diagnostics.
• Advantages include:
  • Rapid results
  • High sensitivity (ability to detect even small amounts of bacterial DNA)

Treatment and Prognosis

• Antibiotic therapy is recommended early, especially in endemic regions.
• Starting treatment before confirmatory test results improves outcomes.
• Timely treatment is associated with a favorable prognosis for EN-related colitis.

Prevention Challenges and Future Research Directions

• Long-term prevention methods are limited currently.
• Developing vaccines that offer broad protection against various bacterial strains is a key research goal.
• Effective vaccines would need to overcome:
  • Strain diversity of Neorickettsia bacteria
  • Requirement for durable immunity to prevent recurrent infections